Just as most of us didn't expect the BO could happen so quickly at this very generous $24/share cash offer (while Briga still hasn't been approved by FDA), the unexpected could happen again and lead to Takeda backing out from the deal, then SP could drop below the privious level under $13/share
Good lucks to those are still holding shares for pennies.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.